Adenosine A(2A) Agonist and A(2B) Antagonist Mediate an Inhibition of Inflammation-induced Contractile Disturbance of a Rat Gastrointestinal Preparation

Overview

Journal Purinergic Signal

Publisher Springer

Date 2009 Dec 19

PMID 20020217

Citations 10

Authors

Sebastian Michael

Claudia Warstat

Fabien Michel

Luo Yan

Christa E Muller

Karen Nieber

Affiliations

Soon will be listed here.

Abstract

Adenosine can show anti-inflammatory as well as pro-inflammatory activities. The contribution of the specific adenosine receptor subtypes in various cells, tissues and organs is complex. In this study, we examined the effect of the adenosine A(2A) receptor agonist CGS 21680 and the A(2B)R antagonist PSB-1115 on acute inflammation induced experimentally by 2,4,6-trinitrobenzenesulfonic acid (TNBS) on rat ileum/jejunum preparations. Pre-incubation of the ileum/jejunum segments with TNBS for 30 min resulted in a concentration-dependent inhibition of acetylcholine (ACh)-induced contractions. Pharmacological activation of the A(2A)R with CGS 21680 (0.1-10 microM) pre-incubated simultaneously with TNBS (10 mM) prevented concentration-dependently the TNBS-induced inhibition of the ACh contractions. Stimulation of A(2B)R with the selective agonist BAY 60-6583 (10 microM) did neither result in an increase nor in a further decrease of ACh-induced contractions compared to the TNBS-induced inhibition. The simultaneous pre-incubation of the ileum/jejunum segments with TNBS (10 mM) and the selective A(2B)R antagonist PSB-1115 (100 microM) inhibited the contraction-decreasing effect of TNBS. The effects of the A(2A)R agonist and the A(2B)R antagonist were in the same range as the effect induced by 1 microM methotrexate. The combination of the A(2A)R agonist CGS 21680 and the A(2B)R antagonist PSB-1115 at subthreshold concentrations of both agents found a significant amelioration of the TNBS-diminished contractility. Our results demonstrate that the activation of A(2A) receptors or the blockade of the A(2B) receptors can prevent the inflammation-induced disturbance of the ACh-induced contraction in TNBS pre-treated small intestinal preparations. The combination of both may be useful for the treatment of inflammatory bowel diseases.

Citing Articles

Adenosine-mediated immune responses in inflammatory bowel disease.

Vuerich M, Nguyen D, Ferrari D, Longhi M Front Cell Dev Biol. 2024; 12:1429736.

PMID: 39188525 PMC: 11345147. DOI: 10.3389/fcell.2024.1429736.

Control of Gut Inflammation by Modulation of Purinergic Signaling.

Vuerich M, Mukherjee S, Robson S, Longhi M Front Immunol. 2020; 11:1882.

PMID: 33072065 PMC: 7544737. DOI: 10.3389/fimmu.2020.01882.

MicroRNA-16 is putatively involved in the NF-κB pathway regulation in ulcerative colitis through adenosine A2a receptor (A2aAR) mRNA targeting.

Tian T, Zhou Y, Feng X, Ye S, Wang H, Wu W Sci Rep. 2016; 6:30824.

PMID: 27476546 PMC: 4967855. DOI: 10.1038/srep30824.

Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors.

Alnouri M, Jepards S, Casari A, Schiedel A, Hinz S, Muller C Purinergic Signal. 2015; 11(3):389-407.

PMID: 26126429 PMC: 4529847. DOI: 10.1007/s11302-015-9460-9.

An adenosine A3 receptor agonist inhibits DSS-induced colitis in mice through modulation of the NF-κB signaling pathway.

Ren T, Tian T, Feng X, Ye S, Wang H, Wu W Sci Rep. 2015; 5:9047.

PMID: 25762375 PMC: 4357005. DOI: 10.1038/srep09047.

References

Guieu R, Dussol B, Devaux C, Sampol J, Brunet P, Rochat H . Interactions between cyclosporine A and adenosine in kidney transplant recipients. Kidney Int. 1998; 53(1):200-4. DOI: 10.1046/j.1523-1755.1998.00727.x. View

Odashima M, Otaka M, Jin M, Komatsu K, Wada I, Horikawa Y . Attenuation of gastric mucosal inflammation induced by aspirin through activation of A2A adenosine receptor in rats. World J Gastroenterol. 2006; 12(4):568-73. PMC: 4066089. DOI: 10.3748/wjg.v12.i4.568. View

Kolachala V, Ruble B, Vijay-Kumar M, Wang L, Mwangi S, Figler H . Blockade of adenosine A2B receptors ameliorates murine colitis. Br J Pharmacol. 2008; 155(1):127-37. PMC: 2440087. DOI: 10.1038/bjp.2008.227. View

Cronstein B, Montesinos M, Weissmann G . Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB. Proc Natl Acad Sci U S A. 1999; 96(11):6377-81. PMC: 26889. DOI: 10.1073/pnas.96.11.6377. View

Wood J . Enteric neuroimmunophysiology and pathophysiology. Gastroenterology. 2004; 127(2):635-57. DOI: 10.1053/j.gastro.2004.02.017. View

Palmer T, Trevethick M . Suppression of inflammatory and immune responses by the A(2A) adenosine receptor: an introduction. Br J Pharmacol. 2007; 153 Suppl 1:S27-34. PMC: 2268038. DOI: 10.1038/sj.bjp.0707524. View

Jacobson K, Gao Z . Adenosine receptors as therapeutic targets. Nat Rev Drug Discov. 2006; 5(3):247-64. PMC: 3463109. DOI: 10.1038/nrd1983. View

Fozard J, Ellis K, Villela Dantas M, Tigani B, Mazzoni L . Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat. Eur J Pharmacol. 2002; 438(3):183-8. DOI: 10.1016/s0014-2999(02)01305-5. View

Kuno A, Critz S, Cui L, Solodushko V, Yang X, Krahn T . Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusion. J Mol Cell Cardiol. 2007; 43(3):262-71. PMC: 2729547. DOI: 10.1016/j.yjmcc.2007.05.016. View

10.

Kolachala V, Asamoah V, Wang L, Obertone T, Ziegler T, Merlin D . TNF-alpha upregulates adenosine 2b (A2b) receptor expression and signaling in intestinal epithelial cells: a basis for A2bR overexpression in colitis. Cell Mol Life Sci. 2005; 62(22):2647-57. PMC: 11138373. DOI: 10.1007/s00018-005-5328-4. View

11.

Kolachala V, Bajaj R, Chalasani M, Sitaraman S . Purinergic receptors in gastrointestinal inflammation. Am J Physiol Gastrointest Liver Physiol. 2007; 294(2):G401-10. DOI: 10.1152/ajpgi.00454.2007. View

12.

Abo-Salem O, Hayallah A, Bilkei-Gorzo A, Filipek B, Zimmer A, Muller C . Antinociceptive effects of novel A2B adenosine receptor antagonists. J Pharmacol Exp Ther. 2003; 308(1):358-66. DOI: 10.1124/jpet.103.056036. View

13.

Link A, Kino T, Worth J, Mcguire J, Crane M, Chrousos G . Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes. J Immunol. 1999; 164(1):436-42. DOI: 10.4049/jimmunol.164.1.436. View

14.

BAUMGOLD J, Nikodijevic O, Jacobson K . Penetration of adenosine antagonists into mouse brain as determined by ex vivo binding. Biochem Pharmacol. 1992; 43(4):889-94. PMC: 3425645. DOI: 10.1016/0006-2952(92)90257-j. View

15.

Mabley J, Pacher P, Liaudet L, Soriano F, Hasko G, Marton A . Inosine reduces inflammation and improves survival in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol. 2002; 284(1):G138-44. DOI: 10.1152/ajpgi.00060.2002. View

16.

Sitkovsky M, Lukashev D . Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat Rev Immunol. 2005; 5(9):712-21. DOI: 10.1038/nri1685. View

17.

Gomez G, Sitkovsky M . Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo. Blood. 2003; 102(13):4472-8. DOI: 10.1182/blood-2002-11-3624. View

18.

Antonioli L, Fornai M, Colucci R, Ghisu N, Blandizzi C, Del Tacca M . A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis. Inflamm Bowel Dis. 2006; 12(2):117-22. DOI: 10.1097/01.MIB.0000198535.13822.a9. View

19.

Sullivan G . Adenosine A2A receptor agonists as anti-inflammatory agents. Curr Opin Investig Drugs. 2004; 4(11):1313-9. View

20.

Yan L, Muller C . Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability. J Med Chem. 2004; 47(4):1031-43. DOI: 10.1021/jm0310030. View